Point of Care Diagnostics Market - Global Industry Analysis

Point of Care Diagnostics Market by kits Product (Glucose Monitoring, Infectious Disease Testing, Pregnancy And Fertility Testing, Hematology Testing, Cardiometabolic Monitoring, Urinalysis Testing, Coagulation Monitoring, Tumor Markers Testing, Cholesterol Test Strips, Drugs Of Abuse Testing, and Fecal Occult Testing), Platform (Microfluidics and Immunoassay), End-user (Hospital, E-comm, and Home Care) and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 01-Mar-2022 Category: Healthcare Report Format : PDF Pages: 187 Report Code: ZMR-812 Status : Published

The global point of care diagnostics market size was worth around USD 35.4 billion in 2021 and is estimated to grow to about USD 62.1 billion by 2028, with a compound annual growth rate (CAGR) of approximately 11.5 percent over the forecast period.

Description

Industry Prospective:

The global point of care diagnostics market was worth around USD 35.4 billion in 2021 and is estimated to grow to about USD 62.1 billion by 2028, with a compound annual growth rate (CAGR) of approximately 11.5 percent over the forecast period. The report analyzes the point of care diagnostics market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the point of care diagnostics market.

Point of Care Diagnostics Market: Overview

Point-of-care diagnostics (POCD) is critical for detecting analytes close to the patient, allowing for improved illness monitoring, diagnosis, and management. It allows for rapid medical choices since illnesses can be detected at an early stage, resulting in better health outcomes for patients by allowing for the early initiation of therapy.

COVID-19 Impact:

The role of point of care diagnostic during the pandemic was crucial. The need for POC tests increased double-fold resulting in sharp growth of the global point of care diagnostics market from mid-2020 to 2021. Since the severe acute respiratory syndrome (SARS-CoV-2) virus jumped from an animal population to humans in December 2019, it has quickly spread around the world, posing critical public health challenges such as becoming the leading cause of death in the U.S. in early 2021, disrupting daily life, and causing economic losses to firms & people. The COVID-19 pandemic has underlined the importance of swiftly and properly diagnosing the disease at bigger scales than ever before. Models suggest that millions of tests per day are required to fully remobilize the economy. However, numerous issues have led to less-than-ideal testing availability, including a lack of laboratory supplies (which also affects non-COVID testing) and test kits.

These facts suggest the demand for point of care diagnostics is expected to remain high during the forecast period. Also, increased awareness about POC diagnostic among the patients may increase its adoption in emerging countries.

Global pea protein market

Point of Care Diagnostics Market: Growth Drivers

Rise in prevalence of infectious and chronic diseases is fostering the market growth

Globally, the burden of infectious and chronic diseases is on the rise. Lack of exercise, changes in lifestyle, and unhealthy habits are also some of the factors that are leading to an increase in chronic diseases like diabetes, chronic respiratory diseases, and cardiovascular diseases. According to WHO, cardiovascular disease constitutes the majority of non-communicable diseases mortality (17.9 million per year), followed by cancer (9.3 million), respiratory infections (4.1 million), and diabetes (1.5 million). Additionally, two-thirds of all tuberculosis cases worldwide were traced to just eight countries: South Africa, Bangladesh, Nigeria, Pakistan, the Philippines, China, Indonesia, and India. POC diagnostics can considerably enhance the treatment of infectious illnesses, particularly in underdeveloped nations where prompt medical care is difficult to come by and healthcare infrastructure is limited. Furthermore, government incentives and grants for the introduction of new products are driving the use of modern technology for infectious disease diagnostics. These efforts have made it simpler for people in undeveloped and impoverished nations to afford these tests. Moreover, factors such as the increasing number of clinics implementing POC diagnostics for the quick identification of infectious diseases are likely to fuel the growth of the global point of care diagnostics market.

Point of Care Diagnostics Market: Restraints

Lack of trained professionals in the diagnostic field to hamper market growth.

According to WHO research, a worldwide health concern is a shortage of healthcare workers, which affects access to healthcare services. Low- and middle-income countries are further hampered by a shortage of trained health professionals, and new innovations, such as the adoption of POC diagnostics in medical care, are posing challenges to POCT delivery due to the increasing workload and dearth of skilled health workers.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Point of Care Diagnostics Market: Opportunities

Smart devices equipped with mobile healthcare (mH) to pave way for market expansion

The current POCD trend is firmly leaning toward smart devices integrated with mobile healthcare, which have the potential to genuinely transform customized healthcare monitoring and management, opening the way for next-generation point of care diagnostics. Smartphone POC technologies for the interpretation of colorimetric, chemiluminescent, fluorescence, electrochemical, label-free, and lateral flow assays detection of cells, nanoparticles, biomolecules, and microbes; and other diagnostic applications have previously been developed. The number of cellphone users has now surpassed 7.4 billion, with 70 percent of them living in poor nations with a severe need for POCD. Numerous smartphone gadgets and smart applications for managing and monitoring fundamental health metrics such as blood pressure, blood glucose, pulse rate, body analysis, physical activity, weight, and electrocardiogram have been commercialized. All these factors ensure the healthy growth of the global point of care diagnostics market during the forecast period.

Point of Care Diagnostics Market: Challenges.

Market is likely to face challenges due to high test cost compared to laboratory tests

One of the major challenges for the global point of care diagnostics market is its high cost as compared to laboratory tests. Rural areas and underdeveloped nations still prefer laboratory testing over POC diagnostics which in turn is limiting the market growth. Also, unfavorable reimbursement policies for POC diagnostics have led to low penetration of the market in emerging countries.

Point of Care Diagnostics Market: Segmentation

The global point of care diagnostics market is categorized based on kits product, platform, end-user, and region. Based on the kits product, the global market is bifurcated into infectious disease testing, glucose monitoring, pregnancy & fertility testing, cardiometabolic monitoring, hematology testing, urinalysis testing, coagulation monitoring, cholesterol test strips, tumor markers testing, fecal occult testing, and drugs of abuse testing. Among these, the glucose monitoring segment dominates the market with more than 25 percent of the share. By platform, the market is segregated as microfluidics and immunoassay. The end-user segment of the global market is divided into hospital, home care, and e-comm. In end-users, the home care segment is expected to register the fastest growth during the forecast period.

Recent Developments

On 23 September 2021, Celltrion, a specialist biologics firm, stated that the Department of Defense's Defense Logistics Agency (DLA) has granted Celltrion USA, Inc., a Celltrion affiliate, a purchase agreement for its DiaTrustTM COVID-19 Ag Rapid Test.

Regional Landscape

North America is expected to remain the largest market for point of care diagnostics during the forecast period. Key factors propelling the growth of the market in the region include an increase in the upper-class population, increasing cases of chronic disorders due to changes in food habitats & lifestyle, and growing demand for effective and efficient diagnostics. Further, healthcare infrastructure in major countries in the region such as the US and Canada is well developed and supports advanced treatment & diagnostics systems. Moreover, high spending power on medical treatments is well supported by increasing initiatives by private and public hospitals in the region. Asia Pacific is projected to provide plenty of opportunities for the expansion of the point of care diagnostics market. Large middle-class populations with frequent health problems are triggering the need for efficient diagnostic systems. Besides, increasing awareness regarding POC diagnostics in emerging countries such as India and China is expected to fuel the market growth over the forecast period.

Competitive Landscape

Key players with a major share in the global point of care diagnostics market include Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, Chembio Diagnostics, and Quidel Diagnostics. Other prominent players operating in this market are Trinity Biotech, EKF Diagnostics, and Fluxergy.

Global point of care diagnostics market is segmented as follows:

By Kits Product

  • Glucose monitoring kits
  • Infectious disease testing kits
  • Pregnancy and fertility testing kits
  • Hematology testing kits
  • Cardiometabolic monitoring kits
  • Urinalysis Testing Kits
  • Coagulation Monitoring Kits
  • Tumor Markers Testing Kits
  • Cholesterol Test Strips
  • Drugs of Abuse Testing Kits
  • Fecal Occult Testing Kits
  • Others (Calcium Assay Kits and Immunochemistry Kits)

By Platform

By End Users

  • Rural Hospital
  • Home Care
  • E-comm

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

 

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report description
    • 1.2. Research scope
    • 1.3. Research methodology
    • 1.4. Market research process
    • 1.5. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global point of care diagnostics market, 2016 - 2022 (USD Million)
    • 2.2. Global point of care diagnostics market : Snapshot
  • Chapter 3. Point Of Care Diagnostics – Industry Analysis
    • 3.1. Introduction
    • 3.2. Market Drivers
    • 3.2.1. Drivers for global point of care diagnostics market: Impact analysis
      • 3.2.1.1. Rising geriatric population and growing occurrences of lifestyle diseases
      • 3.2.1.2. Increasing demand for Home-Based POC Devices
      • 3.2.1.3. Technological advancements and new product launches
    • 3.3. Market Restraints
      • 3.3.1. Restraints for global point of care diagnostics market: Impact Analysis
        • 3.3.1.1. High cost of procedure
        • 3.3.1.2. Presence of stringent and time-consuming regulatory framework
    • 3.4. Opportunities
      • 3.4.1. Healthcare Decentralization
      • 3.4.2. Miniaturization of POC Testing Devices
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Point of care diagnostics : Market Attractiveness Analysis
      • 3.6.1. Market Attractiveness Analysis by Product Segment
      • 3.6.2. Market Attractiveness Analysis by Prescription Mode Segment
      • 3.6.3. Market Attractiveness Analysis by End-User Segment
      • 3.6.4. Market Attractiveness Analysis by Regional Segment
  • Chapter 4. Point Of Care Diagnostics Market – Competitive Landscape
    • 4.1. Company Market Share Analysis, 2016
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
      • 4.2.4. Research And Development, Type And Regional Expansion
    • 4.3. Product Portfolio
  • Chapter 5. Point Of Care Diagnostics Market – Product Segment Analysis
    • 5.1. Global Point Of Care Diagnostics Market Overview: By Product
      • 5.1.1. Global Point Of Care Diagnostics Market Revenue Share, By Product, 2015 & 2022
    • 5.2. Glucose Monitoring Kits
      • 5.2.1. Global Point Of Care Diagnostics Market For Glucose Monitoring Kits, 2014 - 2022 (USD Million)
    • 5.3. Cardio-Metabolic Monitoring Kits
      • 5.3.1. Global Point Of Care Diagnostics Market For Cardio-Metabolic Monitoring Kits, 2014 - 2022 (USD Million)
    • 5.4. Kits Infectious Diseases Testing Kits
      • 5.4.1. Global Point Of Care Diagnostics Market For Cardio-Metabolic Monitoring Kits, 2014 - 2022 (USD Million)
    • 5.5. Coagulation Monitoring Kits
      • 5.5.1. Global point of care diagnostics market for coagulation monitoring kits, 2014 - 2022 (USD Million)
    • 5.6. Pregnancy And Fertility Testing Kits
      • 5.6.1. Global point of care diagnostics market for pregnancy and fertility testing kits, 2014 - 2022 (USD Million)
    • 5.7. Tumor/Cancer Markers
      • 5.7.1. Global point of care diagnostics market for tumor/cancer markers, 2014 - 2022 (USD Million)
    • 5.8. Urinalysis Testing Kits
      • 5.8.1. Global point of care diagnostics market for urinalysis testing kits, 2014 - 2022 (USD Million)
    • 5.9. Cholesterol Test Strips
      • 5.9.1. Global point of care diagnostics market cholesterol test strips, 2014 - 2022 (USD Million)
    • 5.10. Hematology Testing kits
      • 5.10.1. Global point of care diagnostics market for hematology testing kits, 2014 - 2022 (USD Million)
    • 5.11. Drugs Of Abuse Testing Kits
      • 5.11.1. Global point of care diagnostics market for drugs of abuse testing kits, 2014 - 2022 (USD Million)
    • 5.12. Fecal Occult Testing Kits
      • 5.12.1. Global point of care diagnostics market for fecal occult testing kits, 2014 - 2022 (USD Million)
    • 5.13. Others
      • 5.13.1. Global point of care diagnostics market for other test, 2014 - 2022 (USD Million)
  • Chapter 6. Point Of Care Diagnostics Market – Prescription Mode Segment Analysis
    • 6.1. Global point of care diagnostics market overview: by prescription mode
      • 6.1.1. Global point of care diagnostics market revenue share, by prescription mode, 2016 & 2022
    • 6.2. prescription based kits
      • 6.2.1. Global point of care diagnostics market for prescription based kits, 2014 - 2022 (USD Million)
    • 6.3. over the counter kits
      • 6.3.1. Global point of care diagnostics market for over the counter kits, 2014 - 2022 (USD Million)
  • Chapter 7. Point Of Care Diagnostics Market – End User Segment Analysis
    • 7.1. Global point of care diagnostics market overview: by end user
      • 7.1.1. Global point of care diagnostics market revenue share, by end user, 2016 & 2022
    • 7.2. Hospitals
      • 7.2.1. Global point of care diagnostics market for Hospitals, 2014 - 2022 (USD Million)
    • 7.3. clinics
      • 7.3.1. Global point of care diagnostics market for clinics, 2014 - 2022 (USD Million)
    • 7.4. ambulatory care settings
      • 7.4.1. Global point of care diagnostics market for ambulatory care settings, 2014 - 2022 (USD Million)
  • Chapter 8. Point Of Care Diagnostics Market – Regional Analysis
    • 8.1. Global Point of care diagnostics Market : Regional Overview
      • 8.1.1. Global point of care diagnostics market revenue share, by region, 2015 & 2022
    • 8.2. North America
      • 8.2.1. North America point of care diagnostics market, 2014 - 2022 (USD Million)
    • 8.3. North America point of care diagnostics market revenue by product, 2014 - 2022 (USD Million)
      • 8.3.1. North America point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
      • 8.3.2. North America point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
      • 8.3.3. U.S.
        • 8.3.3.1. U.S. point of care diagnostics market revenue, by product, 2014 - 2022 (USD Million)
        • 8.3.3.2. U.S. point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
        • 8.3.3.3. U.S. point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
    • 8.4. Europe
      • 8.4.1. Europe point of care diagnostics market, 2014 - 2022 (USD Million)
      • 8.4.2. Europe point of care diagnostics market revenue by product, 2014 - 2022 (USD Million)
      • 8.4.3. Europe point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
      • 8.4.4. Europe point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
      • 8.4.5. UK
        • 8.4.5.1. UK point of care diagnostics market revenue, by product, 2014 - 2022 (USD Million)
        • 8.4.5.2. UK point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
        • 8.4.5.3. UK point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
      • 8.4.6. France
        • 8.4.6.1. France point of care diagnostics market revenue, by product, 2014 - 2022 (USD Million)
        • 8.4.6.2. France point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
        • 8.4.6.3. France point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
      • 8.4.7. Germany
        • 8.4.7.1. Germany point of care diagnostics market revenue, by product, 2014 - 2022 (USD Million)
        • 8.4.7.2. Germany point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
        • 8.4.7.3. Germany point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
    • 8.5. Asia Pacific
      • 8.5.1. Asia Pacific point of care diagnostics market, 2014 - 2022 (USD Million)
      • 8.5.2. Asia Pacific point of care diagnostics market revenue by product, 2014 - 2022 (USD Million)
      • 8.5.3. Asia Pacific point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
      • 8.5.4. Asia Pacific point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
      • 8.5.5. China
        • 8.5.5.1. China point of care diagnostics market revenue, by product, 2014 - 2022 (USD Million)
        • 8.5.5.2. China point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
        • 8.5.5.3. China point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
      • 8.5.6. Japan
        • 8.5.6.1. Japan point of care diagnostics market revenue, by product, 2014 - 2022 (USD Million)
        • 8.5.6.2. Japan point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
        • 8.5.6.3. Japan point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
      • 8.5.7. India
        • 8.5.7.1. India point of care diagnostics market revenue, by product, 2014 - 2022 (USD Million)
        • 8.5.7.2. India point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
        • 8.5.7.3. India point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
    • 8.6. Latin America
      • 8.6.1. Latin America point of care diagnostics market, 2014 - 2022 (USD Million)
      • 8.6.2. Latin America point of care diagnostics market revenue by product, 2014 - 2022 (USD Million)
      • 8.6.3. Latin America point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
      • 8.6.4. Latin America point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
      • 8.6.5. Brazil
        • 8.6.5.1. Brazil point of care diagnostics market revenue, by product, 2014 - 2022 (USD Million)
        • 8.6.5.2. Brazil point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
        • 8.6.5.3. Brazil point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
    • 8.7. Middle East & Africa
      • 8.7.1. Middle East & Africa point of care diagnostics market, 2014 - 2022 (USD Million)
      • 8.7.2. Middle East & Africa point of care diagnostics market revenue by product, 2014 - 2022 (USD Million)
      • 8.7.3. Middle East & Africa point of care diagnostics market revenue, by prescription mode, 2014 - 2022 (USD Million)
      • 8.7.4. Middle East & Africa point of care diagnostics market revenue, by end-user, 2014 - 2022 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. Roche Diagnostics
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business strategies
      • 9.1.5. Recent Developments
    • 9.2. Alere Inc
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent developments
    • 9.3. Danaher Corporation
      • 9.3.1. Company overview
      • 9.3.2. Financial
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
    • 9.4. Abbott Laboratories
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategies
      • 9.4.5. Recent Developments
    • 9.5. Johnson and Johnson
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategies
      • 9.5.5. Recent Developments
    • 9.6. Instrumentation Laboratory
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategies
    • 9.7. Trinity Biotech PLC
      • 9.7.1. Overview
      • 9.7.2. Product portfolio
      • 9.7.3. Business strategies
      • 9.7.4. Recent Developments
    • 9.8. OraSure Technologies Inc
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategies
      • 9.8.5. Recent Developments

Table Of Figures

List of Figures

1. Point Of Care Diagnostics Market Segmentation
2. Global Point Of Care Diagnostics Market Revenue, 2016 – 2022 (USD  Billion) 
3. Point Of Care Diagnostics: Market Attractiveness Analysis, By Product Segment
4. Point Of Care Diagnostics: Market Attractiveness Analysis, By Prescription Mode
5. Point Of Care Diagnostics: Market Attractiveness Analysis, By End-User Segment
6. Point Of Care Diagnostics: Market Attractiveness Analysis, By Regional Segment
7. Global Point Of Care Diagnostics Market Revenue Share By Delivery Mode, 2016 – 2022
8. Global Glucose Monitoring Kits Market, 2014 – 2022
9. Global Cardiometabolic Monitoring Kits Market, 2014 – 2022
10. Global Infectious Diseases Testing Kits Market, 2014 – 2022
11. Global Coagulation Monitoring Kits Market, 2014 – 2022
12. Global Pregnancy And Fertility Testing Kits Market, 2014 – 2022
13. Global Tumor/Cancer Markers Market, 2014 – 2022
14. Global Urinalysis Testing Kits Market, 2014 – 2022
15. Global Cholesterol Test Strips Market, 2014 – 2022
16. Global Hematology Testing Kits Market, 2014 – 2022
17. Global Point Of Care Diagnostics Market Revenue Share By Prescription Mode, 2016 – 2022
18. Global Prescription-based Testing Kits Market, 2014 – 2022
19. Global Over-the-counter (OTC) Testing Kits Market, 2014 – 2022
20. Global Point Of Care Diagnostics Market Revenue Share By End-user, 2014 – 2022
21. Global Point Of Care Diagnostics Market For Hospitals, 2014 – 2022 (USD  Billion) 
22. Global Point Of Care Diagnostics Market For Clinics, 2014 – 2022 (USD  Billion) 
23. Global Point Of Care Diagnostics Market For Ambulatory Care Settings, 2014 – 2022 (USD  Billion) 
24. Global Point Of Care Diagnostics Market Revenue Share By Region, 2014 – 2022


Table Of Tables

List of Tables

1. Global point of care diagnostics market estimates and forecast, 2016 – 2022 (USD Billion)
2. Global point of care diagnostics market, by region, 2014 – 2022 (USD Billion)
3. Global point of care diagnostics market, by application, 2014 – 2022 (USD Billion)
4. Global point of care diagnostics market, by end-use, 2014 – 2022 (USD Billion)
5. point of care diagnostics – Key market driver analysis
6. point of care diagnostics – Key market restraint analysis
7. North America point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion) 
8. North America point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion) 
9. North America point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion) 
10. U.S. point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion) 
11. U.S. point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
12. U.S. point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
13. Europe point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion) 
14. Europe point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion) 
15. Europe point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion) 
16. Germany point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
17. Germany point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
18. Germany point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
19. France point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
20. France point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
21. France point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
22. UK point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
23. UK point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
24. UK point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
25. Asia Pacific point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
26. Asia Pacific point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
27. Asia Pacific point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
28. China point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
29. China point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
30. China point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
31. Japan point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
32. Japan point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
33. Japan point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
34. India point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
35. India point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
36. India point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
37. Latin America point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
38. Latin America point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
39. Latin America point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
40. Brazil point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
41. Brazil point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
42. Brazil point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)
43. Middle East and Africa point of care diagnostics market revenue, by product, 2014 – 2022 (USD Billion)
44. Middle East and Africa point of care diagnostics market revenue, by prescription mode, 2014 – 2022 (USD Billion)
45. Middle East and Africa point of care diagnostics market revenue, by end-use, 2014 – 2022 (USD Billion)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Point Of Care Diagnostics market. Zion Research has collected and analyzed key data belong to the global Point Of Care Diagnostics market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Point Of Care Diagnostics across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Point Of Care Diagnostics industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases, and market reports

News articles, press releases, and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Point Of Care Diagnostics market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage, and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

The point of Care diagnostics is a medical testing performed at a clinical laboratory in close proximity to where the patient is receiving care. POCT is usually performed by non-laboratory persons and the results are used for clinical decision making. Point- of-care technologies may enhance the management of different diseases and conditions.  The point of Care diagnostics is of great importance in developing countries. Unfortunately, a major aspect in developing countries is that they often lack modern laboratories, fully automated instruments that provide highly reproducible, quantitative, and hence sensitive and accurate diagnostic results. In order to circumvent these issues, the emergence of rapid and easy-to-use point-of-care (POC) tests can dramatically enhance a physician’s ability to diagnose patients’ diseases rapidly and accurately.

The point of care diagnostics market is expected to witness lucrative growth in the near future. The market is mainly driven by technological advancement and cost-effective and high-quality medical solutions. Moreover, increasing prevalence of target diseases coupled with the rise in the aging population base which is more prone to disease growth are attributive to impact the POCT demand considerably over the years to come. However, the high cost of procedure and presence of stringent and time-consuming ambiguous regulatory framework are expected to hamper the market growth within the forecast period. Nonetheless, increasing demand from emerging economies and health care decentralization may open up new growth avenues in the near future.

Global-Point-of-Care-Diagnostics-Market_011

The market can be segmented on the basis of products into glucose monitoring kits, cardio-metabolic monitoring kits, infectious diseases testing kits, coagulation monitoring kits, pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits and others. Glucose testing held 40% share of the overall market in terms of revenue in 2016. Increasing prevalence of diabetes across the globe is expected to boost the demand for glucose testing in the years to come. The infectious diseases testing kits is expected to grow at the highest CAGR during the forecast period on account of the rise in a number of HIV infected individuals.

Some of the key prescription mode present in the market such as prescription based kits and over the counter kits. Prescription-based testing kits are expected to dominate the market in the near future due to increasing incidence of lifestyle diseases and lack of awareness on over the counter POCT devices. 

Based on the end-use, the market can be segmented into hospitals, clinics, and ambulatory care settings. Clinic segment was the leading segment and it accounted for the large chunk of market share in 2016. Increasing adoption of these tests in the clinics for diagnosis of several infections and monitoring of disease progression by assessment of symptoms and other parameters is expected to boost the demand for POCT in this segment. Home health care is another important segment of this segment.

The global point of care market was dominated by           North America with over 42% share of the total market in 2016. This growth is mainly due to increase prevalence of diseases in the region and presence of favorable government regulations and initiatives pertaining to the development of healthcare infrastructure. Asia Pacific is another important regional market and is expected to show witness fastest growth in the near future. This can be attributed to the presence of high unmet medical needs and technological advancement in healthcare infrastructure, growing medical awareness, and rise in per capita income levels in developing economies of including India and China.

Some of the key players in the market such as Roche Diagnostics, Alere Inc ., Danaher Corporation, Abbott Laboratories, Johnson and Johnson, Instrumentation Laboratory, Trinity Biotech PLC, OraSure Technologies Inc, bioMerieux, Qiagen N.V. and Siemens Healthcare.

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Increasing burden of infectious and chronic diseases due to lack of exercise, changes in lifestyle, and unhealthy habits are also some of the factors that are leading to an increase in chronic diseases like diabetes, chronic respiratory diseases, and cardiovascular diseases which is primarily fueling the demand for point of care diagnostics.

 

According to the Zion Market Research report, the global point of care diagnostics market was worth about 35.4 (USD billion) in 2021 and is predicted to grow to around 62.1 (USD billion) by 2028, with a compound annual growth rate (CAGR) of around 11.5 percent.

 

North America is expected to remain the largest market for point of care diagnostics during the forecast period. Key facts propelling the growth of the market in the region include increase in the upper-class population, increasing cases of chronic disorders due to changes in food habitats and lifestyle, and growing demand for effective and efficient diagnostics.

 

Key players with a major share in the global point of care diagnostics market include Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, Chembio Diagnostics, and Quidel Diagnostics. Other prominent players operating in this market are Trinity Biotech, EKF Diagnostics, and Fluxergy.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed